Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury

Keyphrases

• Mouse Model 100%
• Vascular Endothelial Growth Factor 100%
• Neointima Formation 100%
• Re-epithelialization 100%
• Arterial Injury 100%
• Overexpression 18%
• Adenovirus 9%
• Physiologic 9%
• Sequestration 9%
• Endothelial Repair 9%
• Percutaneous Coronary Intervention 4%
• Mechanism of Action 4%
• Beneficial Effects 4%
• Therapeutic Potential 4%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 4%
• Gene Transfer 4%
• Encoded Protein 4%
• High Affinity 4%
• Co-treatment 4%
• C57BL 4%
• Neointima 4%
• Intimal Hyperplasia 4%
• Mitogen 4%
• Circulating Levels 4%
• Endothelial Injury 4%
• Endothelial Cell Proliferation 4%
• Vascular Endothelial Growth Factor Receptor (VEGFR) 4%
• Systemic Injection 4%
• Vascular Repair 4%
• Recombinant Adenovirus 4%
• Arterial Repair 4%

Medicine and Dentistry

• Vasculotropin 100%
• Neointima 100%
• Artery Injury 100%
• Aflibercept 37%
• Adenoviridae 18%
• Percutaneous Coronary Intervention 6%
• Cell Proliferation 6%
• Endothelial Cell 6%
• Vascular Surgery 6%
• Endothelium Injury 6%
• C57BL/6 6%
• Vasculotropin Receptor 6%
• Gene Transfer 6%
• Intimal Hyperplasia 6%
• Mitogenic Agent 6%
• Vasculotropin C 6%